Mesenchymal Stem Cells Market Size to Reach US$ 6.16 Billion 2023-2028

According to the latest report by IMARC Group, titled, “Mesenchymal Stem Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global mesenchymal stem cells market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.16 Billion by 2028, exhibiting a growth rate (CAGR) of 13.06% during 2023-2028.

Mesenchymal stem cells (MSCs) represent a type of adult stem cell that holds great promise in the field of regenerative medicine. They are present in several tissues in the body, such as bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp. MSCs possess the remarkable ability to differentiate into multiple types of cells, including bone cells, cartilage cells, muscle cells, and fat cells. They release numerous bioactive molecules, such as cytokines, and extracellular vesicles, which have important roles in tissue regeneration and repair. These molecules can stimulate nearby cells to divide and differentiate, promote the formation of new blood vessels, reduce scarring, and aid in tissue remodeling. Owing to their regenerative potential and their ability to modulate the immune system, MSCs are being extensively studied for an extensive range of therapeutic applications across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/mesenchymal-stem-cells-market/requestsample

Mesenchymal Stem Cells Market Trends and Drivers:

The mesenchymal stem cells market is primarily driven by the inflating healthcare expenditure and the growing prevalence of chronic diseases, especially among the geriatric population across countries. Additionally, the rising demand for effective therapies that can address the underlying causes of these health conditions is acting as another significant growth-inducing factor. In line with this, the elevating use of MSCs in promoting tissue repair and regeneration, making them a potential solution for various medical conditions, is also positively influencing the global market. Moreover, the escalating limitations and safety concerns associated with traditional treatment, the continuous improvements in healthcare infrastructure, and the expanding awareness among the population about the potential benefits of MSC-based therapies are expected to bolster the mesenchymal stem cells market in the coming years.

Mesenchymal Stem Cells Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

• ATCC
• Axol Bioscience Ltd.
• Cell Applications Inc.
• Celprogen Inc.
• Cyagen Biosciences Inc.
• Lonza Group AG
• Merck KGaA
• PromoCell GmbH
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific Inc.

The report has segmented the market based on product & services, type, source of isolation, indication, and application.

Breakup by Product & Services:

• Products
  • Cells and Cell Lines
  • Kits, Media, and Reagents
  • Others
• Services

Breakup by Type:

• Autologous
• Allogeneic

Breakup by Source of Isolation:

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

Breakup by Indication:

• Bone and Cartilage Repair
• Cardiovascular Disease
• Inflammatory and Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

Breakup by Application:

• Disease Modelling
• Drug Development and Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies

Breakup by Region:

• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8062&flag=C

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporation.

See Campaign: https://www.imarcgroup.com/

Contact Information:

Contact us: IMARC Group Email: sales@imarcgroup.com USA: +1-631-791-1145 | Asia: +91-120-433-0800 Address: 134 N 4th St. Brooklyn, NY 11249, USA Website: https://www.imarcgroup.com/ Follow us on Twitter: @imarcglobal Linkedin: https://www.linkedin.com/company/imarc-group

Tags:
IPS, Extended Distribution, iCN Internal Distribution, Research Newswire, English